ReviewFrontiers in pharmacology2025
CXCR4-targeted therapy in lung cancer: plerixafor as a promising antimetastatic agent.
Prasanna Srinivasan Ramalingam et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it